.Nature Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for incorporation of individuals along with MASLD as well as measurement of liver outcomes in cardio-- renal-- metabolic tests, when records recommend mechanistically possible benefits as well as medical security-- as well as details factors to consider for trial concept as well as regulative commendation.